Sun Pharma shares fall after big drugmakers get Trump letters; Sandeep Bhatia explains why

Sun Pharma which derives around 20% of its revenues from innovative drugs sold in the US said that they had not received any such communication.

Leave a Reply

Your email address will not be published. Required fields are marked *